BACKGROUND
Black race is associated with prostate cancer (PC) diagnosis and poor outcome. Previously, we found black men undergoing radical prostatectomy (RP) in equal access hospitals had increased biochemical recurrence (BCR) risk, but recurrences were equally aggressive as white men. We examined the association between race and long-term outcomes after RP.
METHODS
We analyzed data on 1665 (37%) black and 2791 (63%) white men undergoing RP. Using Cox models, we tested the association between race and BCR, BCR with PSA doubling time <9 months (aggressive recurrence, PSADT), metastases, PC-specific death, and overall death.
RESULTS
At 102-months median follow-up, 1566 (35%) had BCR, 217 (6%) aggressive recurrence, 193 (4%) metastases, and 1207 (27%) died, of which 107 (2%) from PC. White men were older, had lower pre-operative PSA, lower biopsy and pathological grade, more capsular penetration, but less seminal vesicle invasion and positive margins versus black men (all p<0.05). Black men had more recent surgery year (p<0.001). On univariable analysis, black race was associated with increased BCR (p=0.003) and overall death (p=0.017). On multivariable analysis, black race was not associated with BCR (HR:1.07, p=0.26), PSADT (HR:1.14, p=0.42), metastasis (HR:1.24, p=0.21), PC-specific death (HR:1.03, p=0.91), or overall death (HR:1.03, p=0.67).
CONCLUSIONS
Among men undergoing RP at equal access centers, though black men had increased BCR risk, they had similar aggressive recurrence, metastasis, and PC-specific death risk versus white men, and BCR risk was similar after controlling for risk parameters. Longer follow-up is needed to confirm these findings.